Could concentration of matrix metalloproteinase-9 in serum of COPD patients change into the basic disease progress and a degree of airway obstruction? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo Source: Eur Respir J 2002; 20: 170-176 Year: 2002
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients Source: Eur Respir J 2005; 25: 885-890 Year: 2005
Correlation of serum Matrix metalloproteinase-9 and clinico-functional parameters in COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Relationship between sputum level of matrix metallopreteinase (MMP-9)/tissue inhibitor of metalloproteinase (TIMP-1) and methacholine bronchial hyper-reactivity in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Matrix metalloproteinase 2 expression in distal lung of fatal asthma Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006
Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Osteopontin and matrix metalloproteinase-7 in bronchoalveolar lavage as markers of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Relationship between Ca19.9 levels in bronchoalveolar lavage, neutrophilic alveolitis, pulmonary function tests and HRCT pattern in pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003
Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 92s Year: 2002
Elevated concentrations of CXCL8 in the nasal mucosal lining fluid of COPD patients as an accessible surrogate measure of bronchial levels Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016
Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Analysis of airway mucin concentration in patients with pulmonary eosinophilia Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Relevance of measurement of serum periostin for diagnosing bronchial asthma and estimating its lung function abnormalities Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012
MMP2, 8, 9 and TIMP1-4 levels in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease and bronchial asthma Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010
The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis Source: Eur Respir J 2015; 46: 384-394 Year: 2015